Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

Apr 4, 2012

30071_dirs_2012-04-04_d9b5a570-e9e1-4717-a747-4c7276aa2761.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-04-02

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-02 ResMed Common Stock A 17429 Acquired 20577.705 Direct

Footnotes

F1: Shares represent Restricted Stock Units that cliff vest on the 4th anniversary of the grant.